-
1
-
-
84867908490
-
-
American Association of Poison Centers, September 8, Retrieved from
-
American Association of Poison Centers. (2011, September 8). Poison control centers applaud DEA's ban of bath salts [Press release]. Retrieved from http://www.aapcc.org/dnn/ Portals/0/DEA%20Ban%20on%20Bath%20 Salts%209.8.2011.pdf
-
(2011)
Poison Control Centers Applaud DEA's Ban of Bath Salts [Press Release]
-
-
-
2
-
-
0004235298
-
-
American Psychiatric Association, (4th ed., text rev.), Washington, DC: Author. Bath salt of the week: Fine China [Web log post]. (2011, October 8). Retrieved from
-
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author. Bath salt of the week: Fine China [Web log post]. (2011, October 8). Retrieved from http://bathsaltsdrug.com/bath-salt-of-the-week/
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
3
-
-
84863994245
-
-
Centers for Disease Control and Prevention, May 20, November 13, 2010-March 31, 2011. Morbidity and Mortality Weekly Report, 60. Retrieved from
-
Centers for Disease Control and Prevention. (2011, May 20). Emergency department visits after use of a drug sold as bath salts"- Michigan, November 13, 2010-March 31, 2011. Morbidity and Mortality Weekly Report, 60. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6019a6.htm
-
(2011)
Emergency Department Visits After Use of a Drug Sold As "bath Salts"- Michigan
-
-
-
4
-
-
80054872333
-
Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online
-
3,4-Methylenedioxypyrovalerone (MDPV), doi:10.1016/j. toxlet.2011.10.002
-
Coppola, M., & Mondola, R. (2011). 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicology Letters, 208, 12-15. doi:10.1016/j. toxlet.2011.10.002
-
(2011)
Toxicology Letters
, vol.208
, pp. 12-15
-
-
Coppola, M.1
Mondola, R.2
-
5
-
-
84857092184
-
-
European Monitoring Centre for Drugs and Addiction, Retrieved from
-
European Monitoring Centre for Drugs and Addiction. (2011). New drugs and emerging trends: Follow-up on mephedrone. Retrieved from http://www.emcdda.europa.eu/online/ annual-report/2011/new-drugs-and-trends/3
-
(2011)
New Drugs and Emerging Trends: Follow-up On Mephedrone
-
-
-
6
-
-
84920769237
-
Federal officials concerned about "bath salts" and related designer drugs
-
Retrieved from
-
Knopf, A. (2011). Federal officials concerned about "bath salts" and related designer drugs. Alcoholism and Drug Abuse Weekly, 23(6). Retrieved from http://www.alcoholismdrugabuseweekly.com/sample-articles/federal-officials-concerned-bath-salts-designer-drugs.aspx
-
(2011)
Alcoholism and Drug Abuse Weekly
, vol.23
, Issue.6
-
-
Knopf, A.1
-
8
-
-
80355125371
-
Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat
-
Meng, H., Cao, J., Kang, J., Ying, X., Ji, J., Reynolds, W., & Rampe, D. (2012). Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat. Toxicology Letters, 208, 62-68.
-
(2012)
Toxicology Letters
, vol.208
, pp. 62-68
-
-
Meng, H.1
Cao, J.2
Kang, J.3
Ying, X.4
Ji, J.5
Reynolds, W.6
Rampe, D.7
-
9
-
-
79958740730
-
Behavioral and rewarding effects of methylone, an analog of MDMA in mice
-
Miyazawa, M., Kojima, T., & Nakaji, S. (2011). Behavioral and rewarding effects of methylone, an analog of MDMA in mice. Hirosaki Medical Journal, 62, 56-71.
-
(2011)
Hirosaki Medical Journal
, vol.62
, pp. 56-71
-
-
Miyazawa, M.1
Kojima, T.2
Nakaji, S.3
-
10
-
-
80052704897
-
Hallucinatory delirium following use of MDPV: "Bath salts
-
Penders, T.M., & Gestring, R. (2011). Hallucinatory delirium following use of MDPV: "Bath salts." General Hospital Psychiatry, 33, 525-526.
-
(2011)
General Hospital Psychiatry
, vol.33
, pp. 525-526
-
-
Penders, T.M.1
Gestring, R.2
-
12
-
-
84857095510
-
-
Redwood Toxicology Laboratory. (n.d.), Retrieved from
-
Redwood Toxicology Laboratory. (n.d.). Designer stimulant drug testing. Retrieved from http://www.redwoodtoxicology.com/services/designer_stimulant_testing.html#tabs-2
-
Designer Stimulant Drug Testing
-
-
-
13
-
-
80052556761
-
-
September 8 "Bath salts" intoxication [Letter to the editor]
-
Ross, E.A., Watson, M., and Goldberger, B. (2011, September 8). "Bath salts" intoxication [Letter to the editor]. New England Journal of Medicine, 365, 967-968.
-
(2011)
New England Journal of Medicine
, vol.365
, pp. 967-968
-
-
Ross, E.A.1
Watson, M.2
Goldberger, B.3
-
14
-
-
79953647218
-
Mephedrone (4-methylmethcathinone; 'meow meow'): Chemical, pharmacological, and clinical issues
-
doi:10.1007/ s00213-010-2070-x
-
Schifano, F., Albanese, A., Fergus, S., Stair, J.L., DeLuca, P., Corazza, O, Ghodse, A.H. (2011). Mephedrone (4-methylmethcathinone; 'meow meow'): Chemical, pharmacological, and clinical issues. Psychopharmacology, 214, 593-602. doi:10.1007/ s00213-010-2070-x
-
(2011)
Psychopharmacology
, vol.214
, pp. 593-602
-
-
Schifano, F.1
Albanese, A.2
Fergus, S.3
Stair, J.L.4
Deluca, P.5
Corazza, O.6
Ghodse, A.H.7
-
15
-
-
80051712042
-
Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States
-
Spiller, H.A., Ryan, M.L., Weston, R.G., & Jansen, J. (2011). Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clinical Toxicology, 49, 499-505
-
(2011)
Clinical Toxicology
, vol.49
, pp. 499-505
-
-
Spiller, H.A.1
Ryan, M.L.2
Weston, R.G.3
Jansen, J.4
-
16
-
-
84857092183
-
-
State of New Jersey, Governor Chris Christie Signs Legislation Banning Designer Drugs Labeled As Bath Salts" [Press Release] August 23, Retrieved from
-
State of New Jersey. (2011, August 23). Governor Chris Christie signs legislation banning designer drugs labeled as bath salts" [Press release]. Retrieved from http://www.state.nj.us/governor/news/news/552011/approved/20110823a.html
-
(2011)
-
-
-
17
-
-
84857096176
-
-
Retrieved From, October). 3,4-methylenedioxypyrovalerone, U.S. Drug Enforcement Administration
-
U.S. Drug Enforcement Administration. (2011a, October). 3,4-methylenedioxypyrovalerone (MDPV). Retrieved from http://www.deadiversion.usdoj.gov/drugs_concern/mdpv.pdf
-
(2011)
MDPV
-
-
-
19
-
-
79960603129
-
Mephedrone: Use, subjective effects, and health risks
-
doi:10.1111/j.1360-0443.2011.03502.x
-
Winstock, A., Mitcheson, L., Ramsey, J., Davies, S., Puchnarewicz, M., & Marsden, J. (2011). Mephedrone: Use, subjective effects, and health risks. Addiction, 106, 1991-1996. doi:10.1111/j.1360-0443.2011.03502.x
-
(2011)
Addiction
, vol.106
, pp. 1991-1996
-
-
Winstock, A.1
Mitcheson, L.2
Ramsey, J.3
Davies, S.4
Puchnarewicz, M.5
Marsden, J.6
-
20
-
-
78650015521
-
Mephedrone, new kid for the chop?
-
doi:10.1111/j.13600443.2010.03130.x
-
Winstock, A.R., Mitcheson, L.R., DeLuca, P., Davey, Z., Corazza, O., & Schifano, F. (2011). Mephedrone, new kid for the chop? Addiction, 106, 154-161. doi:10.1111/j.13600443.2010.03130.x
-
(2011)
Addiction
, vol.106
, pp. 154-161
-
-
Winstock, A.R.1
Mitcheson, L.R.2
Deluca, P.3
Davey, Z.4
Corazza, O.5
Schifano, F.6
|